Rapidly progressive brain atrophy in septic ICU patients: a retrospective descriptive study using semiautomatic CT volumetry.


Journal

Critical care (London, England)
ISSN: 1466-609X
Titre abrégé: Crit Care
Pays: England
ID NLM: 9801902

Informations de publication

Date de publication:
29 Nov 2021
Historique:
received: 25 08 2021
accepted: 17 11 2021
entrez: 30 11 2021
pubmed: 1 12 2021
medline: 29 12 2021
Statut: epublish

Résumé

Sepsis is often associated with multiple organ failure; however, changes in brain volume with sepsis are not well understood. We assessed brain atrophy in the acute phase of sepsis using brain computed tomography (CT) scans, and their findings' relationship to risk factors and outcomes. Patients with sepsis admitted to an intensive care unit (ICU) and who underwent at least two head CT scans during hospitalization were included (n = 48). The first brain CT scan was routinely performed on admission, and the second and further brain CT scans were obtained whenever prolonged disturbance of consciousness or abnormal neurological findings were observed. Brain volume was estimated using an automatic segmentation method and any changes in brain volume between the two scans were recorded. Patients with a brain volume change < 0% from the first CT scan to the second CT scan were defined as the "brain atrophy group (n = 42)", and those with ≥ 0% were defined as the "no brain atrophy group (n = 6)." Use and duration of mechanical ventilation, length of ICU stay, length of hospital stay, and mortality were compared between the groups. Analysis of all 42 cases in the brain atrophy group showed a significant decrease in brain volume (first CT scan: 1.041 ± 0.123 L vs. second CT scan: 1.002 ± 0.121 L, t (41) = 9.436, p < 0.001). The mean percentage change in brain volume between CT scans in the brain atrophy group was -3.7% over a median of 31 days, which is equivalent to a brain volume of 38.5 cm Many ICU patients with severe sepsis who developed prolonged mental status changes and neurological sequelae showed signs of brain atrophy. Patients with rapidly progressive brain atrophy were more likely to have required mechanical ventilation.

Sections du résumé

BACKGROUND BACKGROUND
Sepsis is often associated with multiple organ failure; however, changes in brain volume with sepsis are not well understood. We assessed brain atrophy in the acute phase of sepsis using brain computed tomography (CT) scans, and their findings' relationship to risk factors and outcomes.
METHODS METHODS
Patients with sepsis admitted to an intensive care unit (ICU) and who underwent at least two head CT scans during hospitalization were included (n = 48). The first brain CT scan was routinely performed on admission, and the second and further brain CT scans were obtained whenever prolonged disturbance of consciousness or abnormal neurological findings were observed. Brain volume was estimated using an automatic segmentation method and any changes in brain volume between the two scans were recorded. Patients with a brain volume change < 0% from the first CT scan to the second CT scan were defined as the "brain atrophy group (n = 42)", and those with ≥ 0% were defined as the "no brain atrophy group (n = 6)." Use and duration of mechanical ventilation, length of ICU stay, length of hospital stay, and mortality were compared between the groups.
RESULTS RESULTS
Analysis of all 42 cases in the brain atrophy group showed a significant decrease in brain volume (first CT scan: 1.041 ± 0.123 L vs. second CT scan: 1.002 ± 0.121 L, t (41) = 9.436, p < 0.001). The mean percentage change in brain volume between CT scans in the brain atrophy group was -3.7% over a median of 31 days, which is equivalent to a brain volume of 38.5 cm
CONCLUSIONS CONCLUSIONS
Many ICU patients with severe sepsis who developed prolonged mental status changes and neurological sequelae showed signs of brain atrophy. Patients with rapidly progressive brain atrophy were more likely to have required mechanical ventilation.

Identifiants

pubmed: 34844648
doi: 10.1186/s13054-021-03828-7
pii: 10.1186/s13054-021-03828-7
pmc: PMC8628398
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

411

Informations de copyright

© 2021. The Author(s).

Références

Crit Care. 2019 Nov 12;23(1):352
pubmed: 31718695
Mol Neurobiol. 2013 Feb;47(1):394-8
pubmed: 23054679
Crit Care Med. 2013 May;41(5):1229-36
pubmed: 23591209
Mol Neurobiol. 2014 Feb;49(1):380-5
pubmed: 23990375
Front Neuroinform. 2019 Mar 18;13:9
pubmed: 30936828
J Magn Reson Imaging. 2013 Jan;37(1):1-14
pubmed: 23255412
J Intensive Care. 2018 Feb 2;6:7
pubmed: 29435330
Crit Care Med. 2009 Oct;37(10 Suppl):S299-308
pubmed: 20046114
N Engl J Med. 2003 Apr 17;348(16):1546-54
pubmed: 12700374
Crit Care Med. 2016 Aug;44(8):1461-7
pubmed: 26992066
Crit Care Med. 2016 Feb;44(2):381-5
pubmed: 26771784
Crit Care Med. 2012 Jul;40(7):2022-32
pubmed: 22710202
AJNR Am J Neuroradiol. 1983 May-Jun;4(3):699-702
pubmed: 6410835
AJNR Am J Neuroradiol. 2020 Feb;41(2):224-230
pubmed: 32001444
Anesth Analg. 2019 Apr;128(4):772-780
pubmed: 30883422
Crit Care Med. 2006 Mar;34(3):625-31
pubmed: 16521260
JAMA. 2014 Apr 2;311(13):1308-16
pubmed: 24638143
Neurology. 1987 Jul;37(7):1135-40
pubmed: 3496557
J Gerontol A Biol Sci Med Sci. 2006 Dec;61(12):1294-9
pubmed: 17234823
JAMA. 2001 Dec 5;286(21):2703-10
pubmed: 11730446
Crit Care Med. 2019 Feb;47(2):254-263
pubmed: 30653472
Neuroimage. 2012 Jul 16;61(4):957-65
pubmed: 22440645
Crit Care. 2013 Sep 18;17(5):R204
pubmed: 24047502
JAMA. 2013 Mar 20;309(11):1154-62
pubmed: 23512062
Neurobiol Aging. 2019 Nov;83:86-94
pubmed: 31585370
Crit Care Med. 2005 Oct;33(10):2367-72
pubmed: 16215394
Crit Care Med. 1985 Oct;13(10):818-29
pubmed: 3928249
Thromb J. 2019 May 30;17:10
pubmed: 31160889
Crit Care. 2019 Feb 22;23(1):63
pubmed: 30795776
Minerva Anestesiol. 2015 Jul;81(7):776-88
pubmed: 25812488
N Engl J Med. 2012 May 31;366(22):2055-64
pubmed: 22616830
J Appl Physiol Respir Environ Exerc Physiol. 1982 Dec;53(6):1496-1503
pubmed: 6759493
Semin Thromb Hemost. 2013 Jul;39(5):559-66
pubmed: 23625756
Dement Geriatr Cogn Disord. 2010;29(5):379-87
pubmed: 20484907
Psychiatry Clin Neurosci. 2003 Jun;57(3):337-9
pubmed: 12753576
Neurocrit Care. 2008;9(3):400-8
pubmed: 18696268
Neurocrit Care. 2020 Apr;32(2):459-468
pubmed: 31187433
Intensive Care Med. 1996 Jul;22(7):707-10
pubmed: 8844239
J Gerontol A Biol Sci Med Sci. 2007 Sep;62(9):1048-55
pubmed: 17895446
Neuroimage. 2005 Jul 1;26(3):839-51
pubmed: 15955494

Auteurs

Ryuta Nakae (R)

Department of Emergency and Critical Care Medicine, Nippon Medical School Hospital, 1-1-5, Sendagi, Bunkyo-ku, Tokyo, 113-8603, Japan. nakae@nms.ac.jp.

Tetsuro Sekine (T)

Department of Radiology, Nippon Medical School Musashi Kosugi Hospital, 1-396, Kosugi-cho, Nakahara-ku, Kawasaki, Kanagawa, 211-8533, Japan.

Takashi Tagami (T)

Department of Emergency and Critical Care Medicine, Nippon Medical School Musashi Kosugi Hospital, 1-396, Kosugi-cho, Nakahara-ku, Kawasaki, Kanagawa, 211-8533, Japan.

Yasuo Murai (Y)

Department of Neurosurgery, Nippon Medical School Hospital, 1-1-5, Sendagi, Bunkyo-ku, Tokyo, 113-8603, Japan.

Eigo Kodani (E)

Department of Radiology, Nippon Medical School Musashi Kosugi Hospital, 1-396, Kosugi-cho, Nakahara-ku, Kawasaki, Kanagawa, 211-8533, Japan.

Geoffrey Warnock (G)

PMOD Technologies Ltd., Sumatrastrasse 25, 8006, Zürich, Switzerland.

Hidetaka Sato (H)

Department of Emergency and Critical Care Medicine, Nippon Medical School Hospital, 1-1-5, Sendagi, Bunkyo-ku, Tokyo, 113-8603, Japan.

Akio Morita (A)

Department of Neurosurgery, Nippon Medical School Hospital, 1-1-5, Sendagi, Bunkyo-ku, Tokyo, 113-8603, Japan.

Hiroyuki Yokota (H)

Graduate School of Medical and Health Science, Nippon Sport Science University, 1221-1, Kamoshida-cho, Aoba-ku, Yokohama, Kanagawa, 227-0033, Japan.

Shoji Yokobori (S)

Department of Emergency and Critical Care Medicine, Nippon Medical School Hospital, 1-1-5, Sendagi, Bunkyo-ku, Tokyo, 113-8603, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH